Current diagnostic and treatment of Raynaud's phenomenon

被引：4

作者：

Caspary, L.

Creutzig, A.

机构：

[1] Klinikum Oststadt, Angiol Gemeinschaftspraxis, D-30159 Hannover, Germany

[2] Klinikum Oststadt, Gefasszentrum, D-30159 Hannover, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2006年 / 131卷 / 21期

关键词：

Raynaud's phenomenon; digital vasospasm; scleroderma; vibration white finger syndrome;

D O I：

10.1055/s-2006-941757

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1223 / 1227

页数：5

共 15 条

[1] Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis [J].

Anderson, ME ;

Moore, TL ;

Hollis, S ;

Jayson, MIV ;

King, TA ;

Herrick, AL .

RHEUMATOLOGY, 2002, 41 (03) :324-328

[2] Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture [J].

Appiah, R ;

Hiller, S ;

Caspary, L ;

Alexander, K ;

Creutzig, A .

JOURNAL OF INTERNAL MEDICINE, 1997, 241 (02) :119-124

[3]

Boin F, 2005, CURR OPIN RHEUMATOL, V17, P752

[4] Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy [J].

Bukhari, M ;

Hollis, S ;

Moore, T ;

Jayson, MIV ;

Herrick, AL .

RHEUMATOLOGY, 2000, 39 (05) :506-512

[5] Digital flow exploration by color Doppler ultrasound in patients with Raynaud's disease or systemic sclerosis [J].

Cazalets, C ;

Cador, B ;

Rolland, Y ;

Decaux, O ;

Guggenbulh, P ;

Chaperon, C ;

Jégo, P ;

Grosbois, B .

JOURNAL DES MALADIES VASCULAIRES, 2004, 29 (01) :12-20

[6] Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine [J].

Coleiro, B ;

Marshall, SE ;

Denton, CP ;

Howell, K ;

Blann, A ;

Welsh, KI ;

Black, CM .

RHEUMATOLOGY, 2001, 40 (09) :1038-1043

[7] Microangiopathy in patients with chronic myelogenous leukemia treated with interferon [J].

Creutzig, A ;

Freund, M ;

Caspary, L ;

Alexander, K .

MICROVASCULAR RESEARCH, 1996, 52 (03) :288-292

[8] Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis [J].

Czupryniak, A ;

Kaluzynska, A ;

Nowicki, M ;

Wiecek, B ;

Bald, E ;

Owczarek, D .

KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (01) :27-31

[9] THE STOCKHOLM WORKSHOP SCALE FOR THE CLASSIFICATION OF COLD-INDUCED RAYNAUDS-PHENOMENON IN THE HAND-ARM VIBRATION SYNDROME (REVISION OF THE TAYLOR-PELMEAR SCALE) [J].

GEMNE, G ;

PYYKKO, I ;

TAYLOR, W ;

PELMEAR, PL .

SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 1987, 13 (04) :275-278

[10] Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon [J].

Marasini, B ;

Massarotti, M ;

Bottasso, B ;

Coppola, R ;

Del Papa, N ;

Maglione, W ;

Comina, DP ;

Maioli, C .

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (04) :253-256

← 1 2 →